American International Group’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-29,386
| Closed | -$89.6K | – | 1904 |
|
2024
Q1 | $89.6K | Sell |
29,386
-253
| -0.9% | -$772 | ﹤0.01% | 2579 |
|
2023
Q4 | $95.4K | Sell |
29,639
-120
| -0.4% | -$386 | ﹤0.01% | 2589 |
|
2023
Q3 | $114K | Buy |
29,759
+1,058
| +4% | +$4.06K | ﹤0.01% | 2436 |
|
2023
Q2 | $94.1K | Buy |
+28,701
| New | +$94.1K | ﹤0.01% | 2615 |
|
2021
Q2 | – | Sell |
-27,729
| Closed | -$111 | – | 3230 |
|
2021
Q1 | $111 | Buy |
27,729
+74
| +0.3% | – | ﹤0.01% | 2661 |
|
2020
Q4 | $64 | Buy |
27,655
+2,055
| +8% | +$5 | ﹤0.01% | 2876 |
|
2020
Q3 | $147K | Sell |
25,600
-583
| -2% | -$3.35K | ﹤0.01% | 2313 |
|
2020
Q2 | $193K | Buy |
+26,183
| New | +$193K | ﹤0.01% | 2139 |
|
2019
Q2 | – | Sell |
-8,401
| Closed | -$15K | – | 3143 |
|
2019
Q1 | $15K | Sell |
8,401
-273
| -3% | -$487 | ﹤0.01% | 3013 |
|
2018
Q4 | $21K | Sell |
8,674
-67
| -0.8% | -$162 | ﹤0.01% | 3018 |
|
2018
Q3 | $50K | Buy |
8,741
+158
| +2% | +$904 | ﹤0.01% | 3065 |
|
2018
Q2 | $67K | Buy |
8,583
+743
| +9% | +$5.8K | ﹤0.01% | 2927 |
|
2018
Q1 | $55K | Buy |
7,840
+4,437
| +130% | +$31.1K | ﹤0.01% | 2880 |
|
2017
Q4 | $34K | Buy |
3,403
+17
| +0.5% | +$170 | ﹤0.01% | 2984 |
|
2017
Q3 | $29K | Buy |
3,386
+254
| +8% | +$2.18K | ﹤0.01% | 2819 |
|
2017
Q2 | $33K | Buy |
+3,132
| New | +$33K | ﹤0.01% | 3032 |
|